Insider · CIK 0001762893
Sriram Ryali
Files at CDXS (CODEXIS, INC.), CRBU (Caribou Biosciences, Inc.). First filing Jan 30, 2025, latest Jan 30, 2025.
In brief
Sriram Ryali files SEC Form 4 as CFO at CRBU (Caribou Biosciences, Inc.), and also at CDXS (CODEXIS, INC.). Since Jan 30, 2025, Sriram Ryali has reported 1 open-market buy worth $25k and 0 open-market sells worth $0, the latest filed on Jan 30, 2025.
A track record needs three past buys with six months of prices behind them; Sriram Ryali has 0, so none is measured yet.
The newest scored trade: bought $25k of CRBU on Jan 29, 2025, filed Jan 30, 2025, scored 30 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRBU: Caribou Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | CRBUbuy Caribou Biosciences, Inc. | $25k 17,360 shares | - | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | CRBU Caribou Biosciences, Inc. | AGrant or award Common Stock | +55,000 | $0.00 | $0 | 72,360 | Feb 20, 2026 |
| Feb 20, 2026 | CRBU Caribou Biosciences, Inc. | AGrant or award Option to purchase Common Stockderivative | +247,500 | $0.00 | $0 | 247,500 | Feb 20, 2026 |
| Jan 29, 2025 | CRBU Caribou Biosciences, Inc. | POpen-market purchase Common Stock | +17,360 | $1.42 | $25k | 17,360 | Jan 30, 2025 |
| Jan 10, 2025 | CRBU Caribou Biosciences, Inc. | AGrant or award Option to purchase Common Stockderivative | +300,000 | $0.00 | $0 | 300,000 | Jan 10, 2025 |
| Jan 1, 2024 | CDXS CODEXIS, INC. | AGrant or award Common Stock | +52,350 | $0.00 | $0 | 175,791 | Jan 2, 2024 |
| Jan 1, 2024 | CDXS CODEXIS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +314,125 | $0.00 | $0 | 314,125 | Jan 2, 2024 |
Questions about Sriram Ryali
Answered from the filings on this page, as of the latest one.
Is Sriram Ryali buying or selling?
Not in the last 12 months. Sriram Ryali's latest open-market trade on SEC Form 4 was bought $25k of CRBU on Jan 29, 2025.
How did Sriram Ryali's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sriram Ryali has 0.
Where does Sriram Ryali file Form 4?
Sriram Ryali has filed Form 4 at CRBU (Caribou Biosciences, Inc.) as Chief Financial Officer; CDXS (CODEXIS, INC.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.